BSX (STOCKS)
Boston Scientific Corp.
$73.670000
-0.580000 (-0.78%)
Prev close: $74.250000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Michael F. Mahoney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $108,942.65M
- Employees
- 53,000
- P/E (TTM)
- 37.87
- P/B (TTM)
- 4.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
15
Strong Buy
22
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.80 | $0.79 | +0.0127 | +1.61% |
|
Sep 2025 (Q3)
|
$0.75 | $0.72 | +0.0293 | +4.07% |
|
Jun 2025 (Q2)
|
$0.75 | $0.73 | +0.0182 | +2.49% |
|
Mar 2025 (Q1)
|
$0.75 | $0.68 | +0.0716 | +10.55% |
Financial Statements
| Revenues | $19.35B |
| Benefits Costs and Expenses | $16.08B |
| Cost Of Revenue | $6.08B |
| Costs And Expenses | $16.08B |
| Gross Profit | $13.27B |
| Operating Expenses | $9.81B |
| Selling, General, and Administrative Expenses | $6.67B |
| Other Operating Expenses | $3.14B |
| Operating Income/Loss | $3.46B |
| Income/Loss From Continuing Operations After Tax | $2.78B |
| Income/Loss From Continuing Operations Before Tax | $3.27B |
| Income Tax Expense/Benefit | $486.00M |
| Interest Expense, Operating | $339.00M |
| Net Income/Loss | $2.78B |
| Net Income/Loss Attributable To Noncontrolling Interest | -$8.00M |
| Net Income/Loss Attributable To Parent | $2.79B |
| Net Income/Loss Available To Common Stockholders, Basic | $2.79B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.88 |
| Diluted Earnings Per Share | $1.87 |
| Basic Average Shares | 1,480,500,000 |
| Diluted Average Shares | 1,495,400,000 |
| Assets | $42.71B |
| Current Assets | $8.04B |
| Inventory | $2.92B |
| Other Current Assets | $5.11B |
| Noncurrent Assets | $34.67B |
| Fixed Assets | $3.80B |
| Intangible Assets | $7.16B |
| Other Non-current Assets | $23.72B |
| Liabilities | $19.08B |
| Current Liabilities | $5.33B |
| Accounts Payable | $1.00B |
| Wages | $1.31B |
| Other Current Liabilities | $3.02B |
| Noncurrent Liabilities | $13.75B |
| Equity | $23.63B |
| Equity Attributable To Noncontrolling Interest | $236.00M |
| Equity Attributable To Parent | $23.39B |
| Liabilities And Equity | $42.71B |
| Net Cash Flow From Operating Activities | $4.63B |
| Net Cash Flow From Operating Activities, Continuing | $4.63B |
| Net Cash Flow From Investing Activities | -$5.83B |
| Net Cash Flow From Investing Activities, Continuing | -$5.83B |
| Net Cash Flow From Financing Activities | $3.00M |
| Net Cash Flow From Financing Activities, Continuing | $3.00M |
| Exchange Gains/Losses | $30.00M |
| Net Cash Flow | -$1.17B |
| Net Cash Flow, Continuing | -$1.20B |
| Comprehensive Income/Loss | $2.22B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$12.00M |
| Comprehensive Income/Loss Attributable To Parent | $2.23B |
| Other Comprehensive Income/Loss | -$566.00M |